A couple of years ago, my dear former colleague and friend Hayley was told she had brain cancer. She was 28. She was given the most life changing news, life shortening diagnosis and had to act now -...

The California Institute for Regenerative Medicine and its partners are selling thousands of stem cell samples before many of them are discarded.

China will also restrict imports of medical devices from other countries that contain EU-made components worth more than 50% of the contract value.

Cigna accused Bristol Myers Squibb of violating antitrust law by keeping generic versions of its blood cancer drug Pomalyst off the market to retain a monopoly.

FDA’s approval of lenacapavir comes at a time when global health cuts could stall its rollout

The FDA has approved Gilead Sciences’ lenacapavir for HIV prevention, making the highly-anticipated twice-yearly shot available to people in the US. It will be marketed as Yeztugo.

It appears that Eli Lilly couldn’t wait to get its hands on Verve Therapeutics’ PCSK9 program. Lilly said Tuesday that it will buy the gene editing biotech for about $1 billion at $10.50 per share.

The genetic-testing company, which collected DNA data from users, is for sale in bankruptcy court. Now, 27 states and the District of Columbia oppose selling the data without express consent.

Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused five clinical trials. Gilead also stressed that the hold does not impact...